Infliximab approved for use in Crohn's disease: a report on the FDA GI Advisory Committee conference

Inflamm Bowel Dis. 1998 Nov;4(4):328-9. doi: 10.1002/ibd.3780040415.
No abstract available

Publication types

  • Congress

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Clinical Trials as Topic
  • Crohn Disease / drug therapy*
  • Drug Approval*
  • Female
  • Humans
  • Infliximab
  • Male
  • Treatment Outcome
  • United States
  • United States Food and Drug Administration

Substances

  • Antibodies, Monoclonal
  • Infliximab